Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study

다국어 초록 (Multilingual Abstract)

Background: Venous thromboembolism (VTE) is rare in pediatric patients compared to adults, but it’s incidence is gradually increasing. The purpose of this study was to analyze the incidence, risk factors, and prognosis of pediatric patients with VTE in Korea.
Methods: Between January 2000 and July 2017, 249,312 medical records of the patients older than 1 year who were hospitalized in the department of pediatrics of 10 university hospitals in Yeungnam region were retrospectively reviewed.
Results: The overall incidence of VTE was 4.9 per 10,000 admissions. Of the total 123 patients, 80 (65.0%) were male and the median age was 10.8 years (range, 1.0-23.5 years). Magnetic resonance imaging was performed most frequently to confirm the diagnosis of VTE (43.1%). Thrombosis occurred in the cerebral vessels (46.3%), lower extremities (23.8%), pulmonary (19.5%), abdomen (9.8%), and upper extremities (4.1%). One hundred and six patients had underlying causes such as cancer (27.6%), infection (26.8%), intravenous catheter insertion (17.9%), and surgery (14.6%). Protein C was evaluated in 39 patients (31.7%), protein S in 40 (32.5%), antithrombin (AT) III in 52 (42.3%), and homocysteine in 21 (17.1%). Among them, one patient with a family history of AT III deficiency had SERPINC gene mutation. Seventy-seven patients (62.6%) started anticoagulation treatment. Most (52.0%) were treated for more than 90 days.
Conclusion: Healthcare providers must be aware of the potential for VTE development in childhood. In the near future, a nationwide survey should be investigated to determine the incidence rate and the trends in VTE among Korean children.

참고문헌 (Reference)

1 최형수, "소아 정맥혈전색전증" 대한소아혈액종양학회 24 (24): 1-10, 2017

2 최형수, "Venous thromboembolism in pediatric patients: a single institution experience in Korea" 대한혈액학회 51 (51): 164-170, 2016

3 van Ommen CH, "Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands" 139 : 676-681, 2001

4 Andrew M, "Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE" 83 : 1251-1257, 1994

5 Connors JM, "Thrombophilia testing and venous thrombosis" 377 : 1177-1187, 2017

6 Marchiori A, "The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies" 92 : 1107-1114, 2007

7 Nowak-Gottl U, "Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors" 97 : 858-862, 2001

8 Kenet G, "Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents-What did we learn within the last 20 years?" 67 : 18-22, 2017

9 Gokce M, "Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors" 23 : 434-439, 2012

10 Setty BA, "Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases" 59 : 258-264, 2012

11 Tuckuviene R, "Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study" 159 : 663-669, 2011

12 Monagle P, "Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry" 47 : 763-766, 2000

13 Schmidt B, "Neonatal thrombosis: report of a prospective Canadian and international registry" 96 : 939-943, 1995

14 Kearon C, "Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial" 112 : 4432-4436, 2008

15 Klaassen ILM, "Increasing incidence and recurrence rate of venous thromboembolism in paediatric oncology patients in one single centre over 25 years" 117 : 2156-2162, 2017

16 Jang MJ, "Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service Database" 9 : 85-91, 2011

17 Baglin T, "Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study" 362 : 523-526, 2003

18 Young G, "Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies" 118 : 1373-1382, 2008

19 Limperger V, "Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study" 175 : 133-140, 2016

20 Goldenberg NA, "Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children" 351 : 1081-1088, 2004

21 de Jong PG, "Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term" 158 : 433-441, 2012

22 Raffini L, "Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007" 124 : 1001-1008, 2009

23 Kerlin BA, "Current and future management of pediatric venous thromboembolism" 87 : S68-S74, 2012

24 Margaglione M, "Coexistence of factor V leiden and factor II A20210 mutations and recurrent venous thromboembolism" 82 : 1583-1587, 1999

25 Creary S, "Clinical course of postthrombotic syndrome in children with history of venous thromboembolism" 23 : 39-44, 2012

26 Monagle P, "Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines" 141 : e737S-801S, 2012